Search Results 1671-1680 of 14774 for anti-TNF drugs

  1. Tofacitinib (Oral Route) Proper Use - Mayo Clinic

    This medicine should come with a Medication Guide. Read and follow the instructions carefully. Ask your doctor if you have any questions.

  2. Radiation Oncology - Clinical trials

    Although radiation therapy to the pelvis has been a standard and important part of treatment for rectal cancer and has been shown to decrease the risk of the ...

  3. Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Immunosuppressive mediations (steroids, tumor necrosis factor (TNF)- ...

  4. Fluorouracil (Intravenous Route, Injection Route) Description and Brand Names - Mayo Clinic

    Fluorouracil belongs to the group of medicines known as antimetabolites. It is used to treat cancer of the colon, rectum, breast, stomach, and pancreas. It may ...

  5. Topotecan (Intravenous Route) Precautions - Mayo Clinic

    Male patients who have female partners should use effective birth control during treatment with this medicine and for at least 3 months after the last dose. If ...

  6. An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... The anti-CD52 monoclonal antibody alemtuzumab ...

  7. Novel stem cell therapy for perianal fistula in pediatric patients with Crohn's disease - Mayo Clinic

    Pediatric onset of Crohn's disease is associated with more-aggressive perianal fistula development. New therapy derives stem cells from patients' fat cells ...

  8. Antithyroid Agent (Oral Route, Rectal Route) Precautions - Mayo Clinic

    While you are being treated with antithyroid agents, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's ...

  9. A Study to Evaluate Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Patients - Mayo Clinic

    About this study. The purpose of this study is to evaluate, jointly and independently among patients deemed at higher risk vs. lower risk for disability ...

  10. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy - Mayo Clinic News Network

    For example, clinical trials have shown that a single infusion of CAR-T cell therapy targeted against a molecule known as BCMA that marks multiple myeloma cells ...